545 related articles for article (PubMed ID: 19747143)
1. Beta-lactamase inhibitors: the story so far.
Pérez-Llarena FJ; Bou G
Curr Med Chem; 2009; 16(28):3740-65. PubMed ID: 19747143
[TBL] [Abstract][Full Text] [Related]
2. β-Lactamases and β-Lactamase Inhibitors in the 21st Century.
Tooke CL; Hinchliffe P; Bragginton EC; Colenso CK; Hirvonen VHA; Takebayashi Y; Spencer J
J Mol Biol; 2019 Aug; 431(18):3472-3500. PubMed ID: 30959050
[TBL] [Abstract][Full Text] [Related]
3. Cyclic Boronates Inhibit All Classes of β-Lactamases.
Cahill ST; Cain R; Wang DY; Lohans CT; Wareham DW; Oswin HP; Mohammed J; Spencer J; Fishwick CW; McDonough MA; Schofield CJ; Brem J
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115348
[TBL] [Abstract][Full Text] [Related]
4. Broad-Spectrum Inhibitors against Class A, B, and C Type β-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization.
Farhat N; Gupta D; Ali A; Kumar Y; Akhtar F; Kulanthaivel S; Mishra P; Khan F; Khan AU
Microbiol Spectr; 2022 Oct; 10(5):e0045022. PubMed ID: 36069578
[TBL] [Abstract][Full Text] [Related]
5. Potential involvement of beta-lactamase homologous proteins in resistance to beta-lactam antibiotics in gram-negative bacteria of the ESKAPEE group.
de Souza J; Vieira AZ; Dos Santos HG; Faoro H
BMC Genomics; 2024 May; 25(1):508. PubMed ID: 38778284
[TBL] [Abstract][Full Text] [Related]
6. Structure, Function of Serine and Metallo-β-lactamases and their Inhibitors.
Salahuddin P; Kumar A; Khan AU
Curr Protein Pept Sci; 2018; 19(2):130-144. PubMed ID: 28745223
[TBL] [Abstract][Full Text] [Related]
7. Resistance to beta-lactam antibiotics: structure and mechanism based design of beta-lactamase inhibitors.
Sandanayaka VP; Prashad AS
Curr Med Chem; 2002 Jun; 9(12):1145-65. PubMed ID: 12052169
[TBL] [Abstract][Full Text] [Related]
8. Combination beta-lactam and beta-lactamase-inhibitor products: antimicrobial activity and efficiency of enzyme inhibition.
Rotschafer JC; Ostergaard BE
Am J Health Syst Pharm; 1995 Mar; 52(6 Suppl 2):S15-22. PubMed ID: 7606585
[TBL] [Abstract][Full Text] [Related]
9. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684
[TBL] [Abstract][Full Text] [Related]
10. Class D β-lactamases: a reappraisal after five decades.
Leonard DA; Bonomo RA; Powers RA
Acc Chem Res; 2013 Nov; 46(11):2407-15. PubMed ID: 23902256
[TBL] [Abstract][Full Text] [Related]
11. Approaches for the discovery of metallo-β-lactamase inhibitors: A review.
Shi C; Chen J; Kang X; Shen X; Lao X; Zheng H
Chem Biol Drug Des; 2019 Aug; 94(2):1427-1440. PubMed ID: 30925023
[TBL] [Abstract][Full Text] [Related]
12. The discovery and development of modified penicillin- and cephalosporin-derived beta-lactamase inhibitors.
Buynak JD
Curr Med Chem; 2004 Jul; 11(14):1951-64. PubMed ID: 15279575
[TBL] [Abstract][Full Text] [Related]
13. β-Lactamase inhibitors: an update.
Chen J; Shang X; Hu F; Lao X; Gao X; Zheng H; Yao W
Mini Rev Med Chem; 2013 Nov; 13(13):1846-61. PubMed ID: 23895190
[TBL] [Abstract][Full Text] [Related]
14. β-Lactamase inhibitor peptides as the new strategies to overcome bacterial resistance.
Silva ON; Franco OL; Porto WF
Drugs Today (Barc); 2018 Dec; 54(12):737-746. PubMed ID: 30596392
[TBL] [Abstract][Full Text] [Related]
15. Tackling the Antibiotic Resistance Caused by Class A
Eiamphungporn W; Schaduangrat N; Malik AA; Nantasenamat C
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061509
[TBL] [Abstract][Full Text] [Related]
16. A sensitive coupled HPLC/electrospray mass spectrometry assay for SPM-1 metallo-beta-lactamase inhibitors.
Sanchez PA; Toney JH; Thomas JD; Berger JM
Assay Drug Dev Technol; 2009 Apr; 7(2):170-9. PubMed ID: 19505232
[TBL] [Abstract][Full Text] [Related]
17. Impact of beta-lactamases on the clinical use of beta-lactam antibiotics.
Nicolas-Chanoine MH
Int J Antimicrob Agents; 1996 Jun; 7 Suppl 1():S21-6. PubMed ID: 18611775
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of antibiotic resistance and beta-lactamase inhibition by mechanism-based inactivators: perspectives and future directions.
Therrien C; Levesque RC
FEMS Microbiol Rev; 2000 Jul; 24(3):251-62. PubMed ID: 10841972
[TBL] [Abstract][Full Text] [Related]
19. Progress toward inhibitors of metallo-β-lactamases.
McGeary RP; Tan DT; Schenk G
Future Med Chem; 2017 May; 9(7):673-691. PubMed ID: 28504895
[TBL] [Abstract][Full Text] [Related]
20. Novel β-lactam-β-lactamase inhibitor combinations: expectations for the treatment of carbapenem-resistant Gram-negative pathogens.
Karaiskos I; Galani I; Souli M; Giamarellou H
Expert Opin Drug Metab Toxicol; 2019 Feb; 15(2):133-149. PubMed ID: 30626244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]